Mississippi FDA - Search News

FDA adds boxed warning to multiple sclerosis drugs

FDA Tacks Boxed Warning on Teva’s Copaxone, Other MS Drugs

The drugs’ active ingredient, glatiramer acetate, has been linked to more than 80 cases of anaphylaxis worldwide since December 1996 and six patient deaths.

Managed Healthcare Executive · 1d

FDA Adds Boxed Warning to MS Drug Copaxone

Regulatory officials have identified 82 cases worldwide from the FDA Adverse Event Reporting System of anaphylaxis associated with the use of Coxapone and the generic Glatopa that have resulted in hospitalization or death.

The American Journal of Manage… · 1d

FDA Warns of Severe Allergic Reactions With Certain Multiple Sclerosis Drugs

The FDA issued a boxed warning for anaphylaxis risk linked to Glatiramer acetate and Glatopa, used in MS treatment. Anaphylaxis symptoms can appear within an hour of injection and may lead to severe conditions,

Business Insider · 2d

FDA adds boxed warning to Teva’s Copaxone for allergic reaction

The Food and Drug Administration is adding a boxed warning about the risk of an allergic reaction for Teva‘s (TEVA) Copaxone and Sandoz’s

Becker's Hospital Review · 1d

FDA issues warning on anaphylaxis risk with MS drugs

Symptoms of anaphylaxis typically develop within an hour of injection and can include wheezing, difficulty breathing, swelling of the face or throat and hives. In some cases, the reaction can lead to hospitalization or death.

1don MSN

The U.S. Food and Drug Administration has issued a recall on a popular skin moisturizer that's available nationwide. Do you have this product?

2don MSN

Supreme Court seems skeptical of court-shopping claim against vape makers

The FDA says vaping companies are improperly gaming the court system, filing claims in an appeals court they think will be sympathetic to them.

SCOTUSblog3d

Menthol vapes and forum shopping, FDA tobacco control comes before justices

The Supreme Court will hear oral arguments on Tuesday in a clash over whether a North Carolina-based company can challenge the Food and Drug Administration’s denial of its application to market ...

Hosted on MSN6d

FDA beats EMA to most approved new drugs in 2024

On 15 January, the two agencies released respective lists of medicines approved last year. The FDA approved 50 novel drugs ...

Results that may be inaccessible to you are currently showing.

Hide inaccessible results